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Clinician identified barriers to treatment
for individuals in Appalachia with opioid use
disorder following release from prison: a social
ecological approach
Amanda M. Bunting1* , Carrie B. Oser1,2, Michele Staton2,3, Katherine S. Eddens4 and Hannah Knudsen2,3

Abstract
Background: The non-medical use of opioids has reached epidemic levels nationwide, and rural areas have been
particularly affected by increasing rates of overdose mortality as well as increases in the prison population. Individuals
with opioid use disorder (OUD) are at increased risk for relapse and overdose upon reentry to the community due to
decreased tolerance during incarceration. It is crucial to identify barriers to substance use disorder treatment postrelease from prison because treatment can be particularly difficult to access in resource-limited rural Appalachia.
Methods: A social ecological framework was utilized to examine barriers to community-based substance use treatment among individuals with OUD in Appalachian Kentucky following release from prison. Semi-structured qualitative interviews with 15 social service clinicians (SSCs) employed by the Department of Corrections were conducted to
identify barriers at the individual, interpersonal, organizational/institutional level, community, and systems levels. Two
independent coders conducted line-by-line coding to identify key themes.
Results: Treatment barriers were identified across the social ecological spectrum. At the individual-level, SSCs
highlighted high-risk drug use and a lack of motivation. At the interpersonal level, homogenous social networks (i.e.,
homophilious drug-using networks) and networks with limited treatment knowledge inhibited treatment. SSC’s high
case load and probation/parole officer’s limited understanding of treatment were organizational/institutional barriers.
Easy access to opioids, few treatment resources, and a lack of community support for treatment were barriers at the
community level. SSC’s noted system-level barriers such as lack of transportation options, cost, and uncertainty about
the implementation of the Affordable Care Act.
Conclusions: More rural infrastructure resources as well as additional education for family networks, corrections staff,
and the community at large in Appalachia are needed to address barriers to OUD treatment. Future research should
examine barriers from the perspective of other key stakeholders (e.g., clients, families of clients) and test interventions
to increase access to OUD treatment.
Keywords: Opioid use disorder, Barriers to treatment, Rural, Appalachia, Reentry, Treatment, Qualitative research
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Background
The prevalence of individuals with an opioid use disorder (OUD) has increased over the past decade [1–3]. The
opioid epidemic has resulted in other negative consequences, including increasing rates of overdose mortalities, emergency room visits, and HIV/HCV prevalence
[4–6]. It is estimated that from 2001 to 2016, the additional spending on health care, social services, and the
criminal justice system coupled with the associated costs
of loss of lives from overdose have reached 1 trillion dollars [7]. More than half of individuals with OUD have
contact with the criminal justice system [8], highlighting
the crucial need to understand treatment access among
this vulnerable population.
While the entire nation is faced with a public health
epidemic, certain geographic areas have experienced
disproportionate levels of OUD, overdose fatalities, and
HIV/HCV seropositive status [5, 9]. At the epicenter of
the opioid epidemic is rural Appalachia. The Appalachian
states of Kentucky, Ohio, and West Virginia rank among
the top five states for age-adjusted opioid overdose deaths
[10]. The region also suffers disproportionate rates of
opioid related HIV and HCV transmission [5, 11] as use
of opioids exceeds national averages [9, 11, 12]. Despite
the heavy use of opioids, the economic deprivation specific to Appalachia (i.e., low formal education, high rates
of unemployment related to the economy) [11, 13] creates significant challenges to accessing appropriate care.
While medications for addiction treatment (MAT) are an
effective treatment for OUD, Appalachian communities
face barriers to access similar to other rural areas such
as lack of prescribing physicians and long waiting lists
[14–16]. The rurality of Appalachia creates challenges in
accessing substance use disorder treatment due to inadequate transportation [11, 14, 17–19] and a general lack
of health-related services [19, 20]. These barriers can be
especially pronounced among re-entering populations
who already face community reintegration challenges
[21, 22].
Disproportionate rates of opioid use exist among criminal justice-involved individuals [23, 24]. Coupled with
complex substance histories, opioid misuse is associated
with increased involvement in the criminal justice system. OUD is associated with criminal justice involvement
due to illicit drug use and the co-occurring criminal activity, as well as through economically motivated crimes to
obtain opioids [25, 26]. Providing treatment for OUD
among criminal justice-involved individuals is critical,
given associated reductions in drug use, crime, and associated costs [27, 28]. The need for treatment is ever more
pressing as individuals returning home from prisons face
an 129 times greater risk of drug overdose death compared to the general public [29]. However, individuals
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typically return home to limited services; a situation
exacerbated by limited post-release resources [30, 31].
Ensuring recently released populations with substance
use disorders are matched with appropriate care is a crucial public health concern.
The current study sought to understand the barriers to
treatment for OUD among individuals reentering communities in Appalachia from clinicians’ perspectives.
While some research has examined perceived barriers
to MAT from the perspectives of clinicians and criminal
justice agencies [32, 33], limited research has considered
counselor or clinician perspectives to barriers to care in
rural areas [19, 34, 35], with no known studies considering the additional vulnerability of criminal justice status.
To assist in understanding these barriers, the current
study was guided by the social ecological framework [36,
37]. The social ecological model of health proposes that
behavior (i.e., the outcome) is determined by five nested
levels: intrapersonal factors (i.e., characteristics of the
individual), interpersonal factors (i.e., social networks),
institutional factors (i.e., social institutions and organizations with formal and informal rules), community factors
(i.e., relationships among organizations and institutions),
and public policy (i.e., local, state, and national law and
policies). The social ecological model suggests behavior is influenced by the social environment [37]. Assessing behavioral outcomes as affected by the various levels
improves opportunities for interventions attuned to the
appropriate level-specific factors. Utilization of all five
levels of the framework provides the additional advantage of allowing researchers to assess the interaction of
various levels and provide more comprehensive suggestions. Many health interventions focus on the individual
or interpersonal level, and multilevel interventions or
interventions at upper ecological levels are critically lacking [38]. The current research used the five levels of the
social ecological model to identify barriers to OUD treatment through qualitative interviews with social service
clinicians who work with Appalachian individuals reentering society after incarceration. These clinicians are
uniquely qualified to describe such barriers because they
routinely work with re-entering individuals and provide
post-release linkages to care.

Methods
Data collection

All social service clinicians (SSCs) employed in Appalachian counties in Kentucky (n = 15) were invited to participate in the study. The 15 SSCs covered a service area
of 54 Appalachian counties [39]. SSCs are employed by
the Kentucky Department of Corrections (DOC) to provide assessments and referrals to treatment following
release for substance involved parolees. Typically, SSCs
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meet with re-entering individuals within 72 h of their
release. All SSCs who were invited to participate provided
informed consent and were interviewed. Four of the 15
SSCs had additional supervisor duties, which includes
administrative responsibilities and clinical supervision.
Design

Recorded qualitative interviews by a trained interviewer
took place between January and April of 2017 during regular office hours, and in the office of the SSC. All interviews were conducted by the same interviewer, who has
a Master’s degree in Public Administration and over a
decade of experience conducting qualitative interviews
with DOC staff and administrators on other federally
funded projects. Interviews were guided by the social
ecological framework to explore challenges to OUD
treatment in Appalachia related to client characteristics,
social networks, the DOC, substance use disorder treatment, and the health care system. SSC’s views on MAT
were also assessed. Informed consent was obtained and
interviews averaged 39 min (range: 26–64 min). Participants were not allowed monetary compensation as part
of DOC guidelines, thus a picture frame valuing less than
$20 was provided as a token of appreciation. The study
was approved by a university’s Institutional Review Board
and participants were protected by a federal Certificate of
Confidentiality.
Data analysis

The interviews were transcribed verbatim. Identifying
information (i.e., names of individuals, cities, counties)
was removed. Two researchers conducted line-by-line
coding of each interview independently to generate initial codes. Consensus was then used to reach agreement
on the primary codes. Disagreement about codes or
themes were resolved by discussion among the two coders and re-review of the original transcripts. Following
thematic analysis techniques [40], the codes were then
organized thematically according to the social ecological
framework.

Results
All respondents were white females, the majority of
whom had a Master’s degree (73.33%, n = 11). SSCs had
been employed in their current position for an average of
5.5 years, with lengths of tenure ranging from 2 months
to 22 years. One-third (33.3%, n = 5) of the SSCs had previously been employed in corrections as a parole/probation or a correctional officer, and a little over one-fourth
(26.7%, n = 4) had previously worked as a clinician in a
substance use disorder treatment center.
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Individual level barriers

High risk use Several SSCs (n = 5) discussed OUD clients as being significantly more challenging than clients
of the past or clients without OUD. Injection drug use
and the increased risk for overdose made this current
generation of clients particularly high-risk in the eyes
of the SSCs. The clinicians also referred to the high
rate of relapse associated with OUD. Conceptualization of their clients as being at high risk of negative
outcomes was additionally tied to the young age and
limited life experience of clients, as expressed by one
SSC supervisor:
And a lot of times they’re high risk substance abuser
because they tend to use, IV [intravenous] drug
users a lot of time. And over the course of my career
it seems like 10 years ago, 15 years ago you would
not have an IV user until they were in their late 20 s,
early 30 s. Like we didn’t see it. And now they’re coming into the system at 18 and 19 as an IV drug user.
SSC Supervisor #3
Stigma and lack of motivation Over half (n = 8) of the
SSCs referred to specific client characteristics as preventing OUD treatment engagement and subsequent recovery. For these SSCs, clients were stated to be dishonest
and/or lack the motivation necessary to succeed in
recovery. Some SSCs stated their clients were unwilling
to participate, or frequently would use other barriers as
excuses to not participate in services such as SSC aftercare programs or MAT. Sometimes lack of honesty was
thought to stem from embarrassment and stigma, especially among individuals whose OUD developed from a
legitimate medical need:
I think a lot of times they’re embarrassed and don’t
want to be honest. There are a lot of clients that
started out that they were prescribed medications,
and I think they’re very shocked to find themselves in
this situation and that’s an embarrassment and they
don’t want to be honest about that.
SSC # 15

Interpersonal level barriers

Homophilious social networks Most SSCs noted that drug
use was considered normative among the friends and
families of clients (n = 12) indicating homophilious social
networks. Homophily refers to the homogeneity of characteristics among individual’s personal networks [41].
Further, networks tended to remain the same pre- and
post-reentry. This stability of networks, combined with
normative drug use, was discussed at length by SSCs. The
homophilious networks threatened clients’ likelihood of
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recovery, and were observable within the DOC and community at large, as explained here:
It seems that everyone, everyone they know or associate with has been or is currently facing the challenge
of their addiction, the challenges of their addictions
as well. They don’t have sober friends or a sober support system. And a lot of it is generational use. Even
their family are not a good support system because
it’s been so embedded.
SSC Supervisor #4
Networks have limited knowledge of treatment In addition to social networks being homophilious, SSCs stated
that client networks had misperceptions about MAT
(n = 7), particularly when family members had negative
perceptions of pharmacotherapy, as illustrated by the following SSC statement:
The families are like, ‘it’s just another drug that
you’re on, I don’t know why you’re on it, you don’t
need to be on anything else, you’ve been clean for
years or months’- however long they stayed in the jail
or the institution, ‘you don’t need to be on that.’
SSC #14
The normativity of drug use in the clients’ networks
(i.e., homophilious networks), created a lack of knowledge on how to best promote recovery for clients’ OUD.
Specifically, it was perceived that the networks and
clients themselves, do not prioritize certain places or
behaviors that could best promote recovery among clients. As explained by one SSC supervisor:
So it’s like, well if they’re not using heroin or if they’re
not using opioids then alcohol’s not going to hurt
them because that’s not what got them in trouble,
or that’s not what they OD’d [overdosed] on. And so
then what’s the, social norms sometimes get skewed
by their family. And the farther removed you are
from having a bigger, I guess network of people to
associate with, your abnormal looks normal.
SSC Supervisor #3
Thus, the lack of knowledge and perceptions of people
with whom clients have social relationships after their
release from prison present challenges not only to accessing treatment, but also to succeeding even when treatment was made available.
Institutional and organizational level barriers

High SSC caseload A majority (n = 9) of SSCs stated that
large caseloads made their job difficult and was a significant barrier in providing services to their clients. High
caseloads, coupled with responsibility for large geographic areas spread across multiple counties, resulted
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in limited time with each client with months between
appointments. Consider the struggles as stated by one
SSC:
However just time to get to your mobile sites is a
barrier. It takes a lot of time, you’ve got to get up
early. Even two to three hours earlier. Go there. And
of course your schedule is full for even next month,
two months, even three months. So you might have
someone test positive for heroin or even, let’s say,
oxycodone- but you don’t see them for two months
from now.
SSC #14
For this particular SSC, the use of e-mail allowed her to
close some of the time gaps in her previously two-month
long waiting list. The SSC utilized e-mail for initial
assessments to determine if clients needed service recommendations for clients with active drug use or if clients were simply complying with DOC regulations and/
or judge mandates to receive an assessment. Other SSCs
mentioned being accessible by phone or relying on the
probation and parole officers to assess and screen those
with the most immediate needs for referral. One SSC
explained her relationship with the parole and probation
officers in the following statement:
So I do my best to try to make sure that they [the
officers] know kind of triage, so they know who needs
to get on the phone right away, who can wait a week
and go on my schedule when I make it back to that
county.
SSC # 10
Lack of parole/probation officer substance use disorder education While some SSCs relied on probation
and parole officers, many discussed the officers lacked a
general understanding of OUD, treatment options, and
particularly misunderstood MAT. Ten of the SSCs mentioned that probation and parole officers needed more
education on substance use disorders in general and/or
MAT. Additionally, four of the SSCs stated probation and
parole officers would not allow their clients to receive
MAT. Three of these referred to buprenorphine specifically, and one discussed prohibition of methadone. One
SSC explained how she saw the negative perceptions of
MAT among officers:
Unfortunately, I feel like a lot of the treatment
around here is just going and getting the medication
and unfortunately I think that’s where the judges got
the bad taste in their mouths for S uboxone® which
bled over to our officers, because they saw so much
abuse and so little success stories. But the way it
works usually, and what I try to tell the officers is,
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when you have success stories they aren’t walking in
our offices with new charges because they’re a success story so all we see if those clients who are not
using successfully.
SSC #10
Despite often sharing an office with the probation and
parole officers, SSCs received completely different training, and to their knowledge, the officers did not receive
any training on MAT or substance use disorders. There
appeared to be a bureaucratic disconnect in who should
be providing education for the officers, as some SSCs
mentioned educating officers in their offices while others
mentioned the need for officers to receive trainings. SSCs
appeared willing to help officers when presented with
questions as illustrated by the following SSC when asked
about her suggestions for improvements:
Education for the clinicians and even the parole
officers because they play a role in it too. I think
all of us need to work together and so that we can
work together for the benefit of the client. Because a
lot of the officers, don’t even know what it is. They
was asking me about it earlier this morning-what
is Vivitrol®- and I explained it to them, what it is.
But I think that if they, if their department kind of
was educated about it, and present to them, it would
help them more too.
SSC #8
Given the high caseload and many counties of the
SSCs, it is not unsurprising that a disconnect existed in
who should be providing education for the officers.
Community level barriers

Three themes related to community level barriers
emerged in the interviews. Barriers were classified as
community-level if they were considered to exist as a
direct result of the Appalachian communities in which
the clients reside.
Easy access to opioids Three clinicians discussed
the ease of drug availability as a significant barrier to
engaging clients in OUD treatment. While not all SSCs
referred directly to ease of access to opioids as a barrier,
all but one stated that opioid use was rampant among
their client caseloads. Some referred to clients who may
have started with medically necessary prescription opioids and then transitioned to illicit use. One SSC relayed
the following details, highlighting how economic strain
among her clients led them to use heroin:
For instance if somebody’s spending three hundred
eighty dollars a day for four OxyContins and you
can run up to [large urban city] and get a packet
of heroin for eighty-five dollars, you know what are
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you going to do. And that lasts a day and a half,
what are you going to do.
SSC #11
Transitioning from non-medical prescription opioid
use to heroin is often driven by economic factors and
availability but has significant public health impacts,
because the purity of heroin is often unknown which
can lead to increased risk for overdose.
Limited availability of treatment resources Nearly all
of the SSCs expressed frustration over the limited availability of treatment resources in Appalachia (n = 13).
Limited resources referred to the lack of physicians
providing treatment, the limited amount of specialty
inpatient and outpatient treatment programs, long
waiting lists, and the limited availability of self-help
group meetings. Often provision of treatment in the
community was only available through DOC involvement with the support of an SSC, as explained by an
SSC supervisor:
But if you go to the more rural areas in the Appalachia, it may take you a 20 mile drive to get to
your closest AA [Alcoholics Anonymous] meeting,
and that’s at a minimum. If you need a [comorbid care center], you have one or two options.
Inpatient, well it’s not impossible if they’re going
through us. If they’re going through the Department of Corrections we can get them treatment in
a relatively decent time. But if they’re just a regular Joe on the streets, it’s really hard.
SSC #1
The SSCs expressed frustration at the lack of
resources that they faced in rural areas, which were
particularly acute for individuals with co-occurring
mental health needs:
This weekend I faced a crisis with a client that was
terminated from the recovery center due to suicidal ideations, and nobody was at work, and the
hospital didn’t want to take them. The only crisis
center would only keep them for 23 h. So here I was
with a client who has a substance use disorder,
plus mental health, and there’s no services available for that client.
SSC Supervisor #4
Lack of community support A few SSCs highlighted a
unique and potentially important barrier in their rural
communities. Despite the immense harm caused by
opioid use in Appalachia, there was the perception that
in general, communities did not acknowledge OUD as
a chronic relapsing medical condition and knew little about the effectiveness of treatment (n = 5). The
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perception of substance use disorders in rural communities was described by one SSC, as follows:
I guess you can say maybe the community perspective of mental health and substance abuse. It’s the
elephant in the county that they refuse to see….
People don’t perceive it well at all. ‘Just quit, you’re
an addict.’ It’s not really welcome as much. It’s hard
go to treatment or to seek treatment when you’re
embarrassed to even enter a room. And even in
small counties, you may see a person next to you
that is your neighbor. That’s even more embarrassing
in itself.
SSC #14
Not only did the community stigma serve as a barrier,
but one SSC stated there was little willingness to have
addiction services located in the communities- a need
that was critical given the lack of treatment resources, as
previously discussed.
You know if there is some type of treatment center
depending on, nobody wants that next to door to
their business. Nobody wants that next door to
their neighborhood, whatever type of treatment it
is because then you got the folks that loiter outside,
and they smoke. And so then it becomes a barrier to
providing resources.
SSC Supervisor #3

System level barriers

Lack of transportation All but one (n = 14) of the SSCs
mentioned transportation was a significant barrier to
their clients accessing treatment in the community upon
release, particularly the lack of public transportation.
Rural clients often were forced to rely on family networks
for transportation to appointments, which can be even
more problematic given the distance and rough terrain to
reach providers in Appalachian counties. This was often
cited as a source of stress for both the client and the family, as described in the following:
Transportation is a big deal. Even if I have a client
whose nearest provider is the next county, which may
only be twenty minutes or something twenty miles,
we don’t have mass transit so everyone can’t just hop
on a bus and get a ride. And a lot of the time some of
the providers are actually in some of the more rural
counties. So there’s no reason for grandma to have to
go to the store in that county and thus give them a
ride to that area…. So if there’s not a reason for them
to go to that county, then they don’t have a ride there
and so even if we can go through the steps of getting
them an appointment, and getting their medical
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insurance signed up, and getting them an appointment- then a lot of times their ride falls through.
SSC # 10
Limited transportation was primarily explained as a
result of rural sprawl. SSCs also noted that many of their
clients lacked a driver license and most experienced economic strain, which meant the entire household shared
one car. Individuals were also limited due to the lack of
public transportation in their communities:
Even if you’re highly motivated there’s not a bus to
get on. Someone has to have a car and they have to
be willing, and they have to be willing on the day
that you need them to go.
SSC Supervisor # 3
As the quote above illustrates, the lack of public transportation was perceived as a source of strain and potentially de-motivating even among the most motivated
individuals. However, SSCs also mentioned the lack of
driver licenses and reliance on social networks for rides,
indicating a fluidity of this barrier as both occurring on
the individual level yet strained by larger system structures in Appalachia.
Treatments are cost prohibitive OUD treatments
were often viewed as cost prohibitive for clients, in part
because of larger healthcare and pharmaceutical infrastructure issues. Ten of the SSCs mentioned treatment
was hard to obtain due to cost, and the majority of these
referred specifically to MAT, as discussed by one SSC
when asked about the lack of use of MAT by her clients:
Well I think one, is the cost. Unfortunately I don’t
think many know about all of the options for the
medically assisted [treatment]. It’s primarily just the
common Suboxone® and methadone and those are
very expensive generally. They just can’t afford that.
I’ve had several start in that program. And I mean,
300 to 400 dollars a month, that’s just very hard to
maintain.
SSC #15
Uncertain future of the Affordable Care Act (ACA)
While all of the SSCs mentioned insurance in some
capacity, some situated their comments within a context of the Medicaid program, Kentucky’s expansion of
Medicaid to cover uninsured low-income adults, and
the ACA. Nine of the SSCs mentioned how changes to
insurance, ease of Medicaid enrollment, or the ACA specifically improved access to care for their clients, as illustrated here:
Before we had changes with the insurance we would
have trouble finding payer sources. But the change in
the Affordable Care Act helped with that.
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SSC Supervisor #4
At the time of the interviews, the nation was in the
midst of the new presidency of Donald Trump who
made a campaign promise to repeal the Affordable Care
Act, and during data collection, the US Congress voted
on a number of measures to change the ACA. This was
reflected in some of the interviews, as SSCs perceived
changes to the current system as a future barrier to
access for clients:
Right now it’s really good [the health care system]
because they’re eligible for health insurance but if
that changes that will really effect what they’re eligible for and really will affect our job and what we can
do for them.
SSC #6

Discussion
This study of SSCs in Appalachian communities found
several barriers to treatment for individuals with OUD.
These barriers were identified at the levels of individuals,
interpersonal networks, institutions and organizations,
the community, and systems within the social ecological
model. Examination of the barriers within this framework provided a nuanced method to promote suggestions for reducing barriers.
At the individual level, clinicians identified their clients
as high-risk users who were often unmotivated to engage
in treatment. Injection drug use practices facilitates the
transmission of bloodborne infections (e.g., HIV, HCV),
and this concern was noted among the SSCs. Young persons who inject drugs may be at increased risk of infections, owing to sharing needles and drug preparation
equipment with sexual partners or pooling money to buy
drugs and consequent needle sharing [42, 43]. One of the
SSCs mentioned the youth and limited life experiences of
their high-risk clients, and research suggests understanding the social context and relationships of young persons
who inject drugs could assist in lowering risk among this
population [42]. Extant research has indicated motivation
represents a challenge to getting individuals to access
care [44]. However, this research has also demonstrated
that those who may be ‘least motivated’ typically have
the most chronic health problems including injection
drug use [44]. Thus while perceived as stigma and lack
of motivation by SSCs, there could be some individuals
who have become disenfranchised with the lack of services available to them or a feeling of being caught in the
criminal justice system which is not primarily focused on
treatment. Perceived lack of motivation could also stem
from stigma and embarrassment for individuals who first
started using prescription medications stemming from
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legitimate medical concerns before progressing to misuse
and OUD.
Network level barriers included homophilious client
networks with limited substance use disorder treatment
knowledge among network members. The SSC-client
relationship could be expanded to include conversation
or even take-home educational resources for families in
order to help educate client networks. A network-based
intervention could promote SSCs as social influencers
who facilitate treatment, recovery, and healthy lifestyles
not only for their clients, but also have trickle-down positive effects to their client’s networks. However, the institutional and organizational barriers of high SSC caseload
and travel burdens would need to first be overcome in
order for SSCs to have the availability and resources to
provide such an intervention.
Institutional and organizational barriers included high
SSC caseload and lack of probation/parole officer education about OUD. Institution specific barriers to the
DOC (e.g., caseload) would require additionally allocated
resources to reduce burden for SSCs. Additionally, a clear
and perhaps easy to accomplish improvement would
be the provision of substance use education, to include
MAT, for probation and parole officers. A general education seminar would take little resources or time away
from officer supervision duties and could be added to
current training mandates. Provision of education to
overcome discrepancies in employee education is particularly important given the findings that often the DOC
was one of the only service providers available in rural
counties. The education of officers may assist with reversing the prohibition of MAT by some officers. At a more
institutional level, the SSCs reported that judges also prohibited the use of MATs and overcoming this challenge
would require the support of DOC, as well as possibly
state legislation in a more comprehensive approach.
At the community level, SSCs reported that the community lacked both treatment resources and communitylevel support. The lack of treatment resources in rural
areas is by no means a new phenomenon. In addition
to the support for the use of telemedicine in rural areas,
certain advances in MAT may be advantageous for individuals with OUD who would benefit from MAT as part
of their treatment plan [14]. The advent of time-release
formulas (e.g., 
Sublocade®, Vivitrol®) may reduce the
frequency of transportation barriers for eligible individuals. Combined with telemedicine for psychosocial counseling, rural clients could fare better even in the face of
reduced community resources.
Previous research has found health care providers have
reported difficulties in building community relationships
in rural areas [45]. Similar to suggestions for overcoming
physician community distrust, SSCs who live and actively
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participate in their communities in informal ways (e.g.,
church, local festivals) may be presented with informal
opportunities to educate the community [45]. More formal ways to educate the community could include the
DOC encouraging and providing time for SSCs, or even a
specified community liaison, to be present at community
events in more formal capacities (e.g., educational booth,
hosting an event, inter-agency collaborations with public
health departments).
Related to community support was the potential for
community stigma. Rural clients are more likely to have
concerns related to confidentiality due to smaller networks [18, 20]. As one author stated, rural communities
are like “fishbowls” in that the attendance at treatment
is observed by community members, and privacy can
be difficult to protect [34]. Integrating treatment such
as MAT into primary care settings could assist with this
barrier. Further, increased general education for the community could assist in removing the social stigmas associated with substance use disorders, similar to public
health approaches of education for other chronic health
conditions (e.g., diabetes, heart disease).
The ease of access to opioids also presented a challenge
to clients’ treatment. This challenge has been reported
nationwide, but can be particularly pronounced in areas
where nonmedical prescription pain relievers offer a
form of social capital [46], as spurred by the years of ‘pill
mills’ proliferating rural areas. Further, nationwide trends
indicate that cost, ease of access, and policy have resulted
in transition from nonmedical prescription pain relievers
to less expensive heroin [47, 48]. This issue of supply and
access is one that still remains to be addressed via policy
and law enforcement efforts.
Finally, at the systems level, the barriers to care identified by SSCs included lack of transportation, high-cost of
treatments, and uncertainty of the ACA. Having a driver’s license has been shown to significantly increase the
likelihood of health care utilization [17]. Lack of a license
among clients may not be due to individual characteristics, but rather due to systemic issues such as cost or
statutory prohibition of licensing [49]. Provision of rides
from family and friends also increases the likelihood of
chronic care visits; [17] however, as network barriers here
indicate, social networks may not always perceive OUD
as a chronic health condition in need of care and support. Access to transportation could be improved in rural
areas, if current medical transportation that is often limited to older or disabled adults was expanded to include
the current OUD and other substance use disorder populations. However, even these options are not without
significant barriers [17] (e.g., expensive to counties, timeconsuming). New advances in telemedicine could be particularly important among rural individuals with OUD
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[50]. Since telehealth still carries potential infrastructure
and cost burdens, the use of mobile treatment providers
would be additionally beneficial.
While the high cost of treatment has been noted by
other research, [15, 20] a novel contribution of the current interviews was the SSCs perspective and concern
over the ACA. While the individual mandate portion of
the ACA was repealed in October 2017, the ACA and
the portions related to Medicaid remain unchanged as of
this writing. Studies continue to find the ACA has beneficial effects through uninsured rate reductions among
vulnerable populations [51] and in rural areas [52, 53].
Policymakers who are dedicated to addressing the opioid epidemic should continue to support the ACA and
expansion of treatment resources.
This study was not without limitations, which future
research should consider. The study only assessed barriers as perceived by SSCs, a critical perspective given their
role yet additional barriers may be perceived from the
perspectives of clients. The perceptions of clinicians may
be biased, incomplete, or out of touch with the everyday
lived experiences of the clients served. It is also possible
the responses were biased as a result of the SSC’s projecting desired outcomes that were not reflective of all
stakeholders. This study was limited to SSCs in one geographic location—Appalachian Kentucky. While all SSCs
in this area were included in the study, the sample size
was limited. Future research should consider the cultural
nuances of other rural locations, such as the Mississippi
Delta or the rural Southwest. Treatment needs and barriers to access may differ for people released from prison
to other rural regions of the U.S. In addition, there is
wide-variation in the operating procedures of each state’s
Department of Corrections, some of which may not have
staff who serve in a role similar to Kentucky DOC’s SSC.
However, Kentucky DOC has implemented several innovations to address the treatment needs of people who are
under criminal justice system supervision. These strategies include establishing SSC positions to promote linkages to behavioral health services at re-entry, offering
extended release naltrexone in prison and jail at re-entry
for clinically eligible clients who completed a correctional
substance use disorder treatment program, and establishing Recovery Kentucky which created 13 communitybased centers to provide housing and recovery services
for 2000 Kentuckians simultaneously. It is important
to keep in mind the varying educational foundations
that were found to exist within this system, and future
research could consider how perspectives and services
vary by SUD training and education. In addition to identification of barriers from the perspective of others (e.g.,
clients, probation and parole officers), future research
should consider interventions that seek to overcome the
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barriers identified. For example, the use of telemedicine
services as well as mobile treatment providers could be
particularly advantageous in rural communities. Network
and community-level interventions focused on education
of OUD and MAT would additionally be beneficial.
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Conclusions
The current study offered the perspective of clinicians
in assessing the barriers to treatment for opioid use
in resource-limited Appalachian Kentucky. Through
utilization of the social ecological framework, these
barriers were situated as individual, interpersonal,
institutional/organizational, community, and systemlevel. The SSCs in Appalachian Kentucky cited barriers
to treatment to include:, high risk use, stigma and lack
of motivation, homophilious networks, networks with
limited knowledge of treatment, high caseloads, lack
of substance use disorder education for parole/probation officers, limited availability of treatment resources,
ease of access to opioids, lack of community support,
lack of transportation, cost prohibitive treatments, and
an uncertain future of the Affordable Care Act. Identification of these barriers from the perspective of
DOC employed SSCs was critical, as these clinicians
are directly responsible for post-release referrals and
after-care services. Identified suggestions provide realworld opportunities for improving access to treatment
in Appalachia.
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